Skip to main content

Advertisement

SpringerLink
Log in

Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): a case report

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Smith EM, Cohen JA, Pett MA, Beck SL (2010) The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nurs 33(3):173–183

    Article  PubMed  Google Scholar 

  2. Kautio AL, Haanpaa M, Kautiainen H, Kalso E, Saarto T (2011) Burden of chemotherapy-induced neuropathy—a cross-sectional study. Support Care Cancer 19(12):1991–1996

    Article  PubMed  Google Scholar 

  3. Loprinzi CL, Reeves BN, Dakhil SR et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29(11):1472–1478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hershman DL, Weimer LH, Wang A et al (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125:767–774

    Article  CAS  PubMed  Google Scholar 

  5. Cella D, Peterman A, Hudgens S et al (2003) Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 98:822–831

    Article  CAS  PubMed  Google Scholar 

  6. Sweeney CW (2002) Understanding peripheral neuropathy in patients with cancer: background and patient assessment. Clin J Oncol Nurs 6:163–166

    Article  PubMed  Google Scholar 

  7. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL; Alliance for Clinical Trials in Oncology (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309(13): 1359–1367.

  8. Hershman DL, Lacchetti C, Dworkin RH et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941–1967

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Tokyo Hospital, 7-3-1, Bunkyo-ku, Hongo, 113-8655, Tokyo, Japan

    Kae Okuma, Kenshiro Shiraishi & Keiichi Nakagawa

  2. Department of palliative care, University of Tokyo Hospital, 7-3-1, Bunkyo-ku, Hongo, 113-8655, Tokyo, Japan

    Yoshiaki Kanai

Authors
  1. Kae Okuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenshiro Shiraishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiaki Kanai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keiichi Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kae Okuma.

Ethics declarations

Conflict of interests

The authors received no financial support for the research, authorship, and/or publication of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okuma, K., Shiraishi, K., Kanai, Y. et al. Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): a case report. Support Care Cancer 24, 4483–4485 (2016). https://doi.org/10.1007/s00520-016-3349-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3349-1

Keywords

Search

Navigation